Literature DB >> 21784354

The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.

Sterling C Johnson1, Asenath La Rue, Bruce P Hermann, Guofan Xu, Rebecca L Koscik, Erin M Jonaitis, Barbara B Bendlin, Kirk J Hogan, Allen D Roses, Ann M Saunders, Michael W Lutz, Sanjay Asthana, Robert C Green, Mark A Sager.   

Abstract

OBJECTIVE: Apolipoprotein E (APOE) genotypes are associated with variable risk of developing late-onset Alzheimer's disease (LOAD), with APOE epsilon 4 (APOE ε4) having higher risk. A variable poly-T length polymorphism at rs10524523, within intron 6 of the translocase of the outer mitochondrial membrane (TOMM40) gene, has been shown to influence age of onset in LOAD, with very long (VL) poly-T length associated with earlier disease onset, and short poly-T length associated with later onset. In this study, we tested the hypothesis that brain and cognitive changes suggestive of presymptomatic LOAD may be associated with this TOMM40 polymorphism.
METHODS: Among healthy APOE ε3 homozygous adults (N = 117; mean age, 55 years), we compared those who were homozygous for VL/VL (n = 35) TOMM40 poly-T lengths (who were presumably at higher risk) with those homozygous for short (S/S; n = 38) poly-T lengths, as well as those with heterozygous (S/VL; n = 44) poly-T length polymorphisms, on measures of learning and memory and on structural brain imaging.
RESULTS: The VL/VL group showed lower performance than the S/S TOMM40 group on primacy retrieval from a verbal list learning task, a finding which is also seen in early Alzheimer's disease. A dose-dependent increase in the VL TOMM40 polymorphism (from no VL alleles, to S/VL heterozygous, to VL/VL homozygous) was associated with decreasing gray matter volume in the ventral posterior cingulate and medial ventral precuneus, a region of the brain affected early in LOAD.
CONCLUSIONS: These findings among APOE ε3/ε3 late middle-aged adults suggest that a subgroup with VL TOMM40 poly-T lengths may be experiencing incipient LOAD-related cognitive and brain changes. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784354      PMCID: PMC3143375          DOI: 10.1016/j.jalz.2010.11.012

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  39 in total

1.  Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.

Authors:  Mark A Sager; Bruce Hermann; Asenath La Rue
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-12       Impact factor: 2.680

2.  The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

Authors:  Sterling C Johnson; Taylor W Schmitz; Mehul A Trivedi; Michele L Ries; Britta M Torgerson; Cynthia M Carlsson; Sanjay Asthana; Bruce P Hermann; Mark A Sager
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

3.  Cytology and functionally correlated circuits of human posterior cingulate areas.

Authors:  Brent A Vogt; Leslie Vogt; Steven Laureys
Journal:  Neuroimage       Date:  2005-09-06       Impact factor: 6.556

4.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

5.  Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.

Authors:  Lars Bäckman; Sari Jones; Anna-Karin Berger; Erika Jonsson Laukka; Brent J Small
Journal:  Neuropsychology       Date:  2005-07       Impact factor: 3.295

6.  PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

Authors:  N M Kemppainen; S Aalto; I A Wilson; K Någren; S Helin; A Brück; V Oikonen; M Kailajärvi; M Scheinin; M Viitanen; R Parkkola; J O Rinne
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

7.  Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults.

Authors:  Sterling C Johnson; Michele L Ries; Timothy M Hess; Cynthia M Carlsson; Carey E Gleason; Andrew L Alexander; Howard A Rowley; Sanjay Asthana; Mark A Sager
Journal:  Arch Gen Psychiatry       Date:  2007-10

8.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

9.  Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

Authors:  A J Slooter; M Cruts; S Kalmijn; A Hofman; M M Breteler; C Van Broeckhoven; C M van Duijn
Journal:  Arch Neurol       Date:  1998-07

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  70 in total

Review 1.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

2.  Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease.

Authors:  Kimberly Diggle Mueller; Rebecca L Koscik; Lyn S Turkstra; Sarah K Riedeman; Asenath LaRue; Lindsay R Clark; Bruce Hermann; Mark A Sager; Sterling C Johnson
Journal:  J Alzheimers Dis       Date:  2016-10-18       Impact factor: 4.472

3.  TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes.

Authors:  Amber Watts; Heather M Wilkins; Elias Michaelis; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers.

Authors:  Erika J Starks; J Patrick O'Grady; Siobhan M Hoscheidt; Annie M Racine; Cynthia M Carlsson; Henrik Zetterberg; Kaj Blennow; Ozioma C Okonkwo; Luigi Puglielli; Sanjay Asthana; N Maritza Dowling; Carey E Gleason; Rozalyn M Anderson; Nancy J Davenport-Sis; LeAnn M DeRungs; Mark A Sager; Sterling C Johnson; Barbara B Bendlin
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.

Authors:  Alison C Burggren; Zanjbeel Mahmood; Theresa M Harrison; Prabha Siddarth; Karen J Miller; Gary W Small; David A Merrill; Susan Y Bookheimer
Journal:  Alzheimers Dement       Date:  2017-02-07       Impact factor: 21.566

6.  The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.

Authors:  Colton Linnertz; Lauren Anderson; William Gottschalk; Donna Crenshaw; Michael W Lutz; Jawara Allen; Sunita Saith; Mirta Mihovilovic; James R Burke; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2014-01-15       Impact factor: 21.566

7.  Neurovascular Invasion and Histological Grade Serve as the Risk Factors of Cervical Lymph Node Metastases in Early Tongue Squamous Cell Carcinoma.

Authors:  Kailiu Wu; Xi Yang; Liwen Li; Min Ruan; Wei Liu; Wei Lu; Chenping Zhang; Siyi Li
Journal:  Mol Neurobiol       Date:  2015-04-25       Impact factor: 5.590

8.  Using genetics to enable studies on the prevention of Alzheimer's disease.

Authors:  D G Crenshaw; W K Gottschalk; M W Lutz; I Grossman; A M Saunders; J R Burke; K A Welsh-Bohmer; S K Brannan; D K Burns; A D Roses
Journal:  Clin Pharmacol Ther       Date:  2012-11-07       Impact factor: 6.875

Review 9.  APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Authors:  Andrew B Wolf; Richard J Caselli; Eric M Reiman; Jon Valla
Journal:  Neurobiol Aging       Date:  2012-11-16       Impact factor: 4.673

10.  TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder.

Authors:  Martyn McFarquhar; Rebecca Elliott; Shane McKie; Emma Thomas; Darragh Downey; Krisztina Mekli; Zoltan G Toth; Ian M Anderson; J F William Deakin; Gabriella Juhasz
Journal:  Neuropsychopharmacology       Date:  2014-01-29       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.